| Followers | 200 |
| Posts | 25596 |
| Boards Moderated | 0 |
| Alias Born | 04/03/2010 |
Wednesday, July 05, 2023 6:24:06 PM
No, that's not how it is available to US patients. And no one is claiming that currently. It is not available in the US.
Patients in the us can freeze their tumors properly, that is the first suggestion by the doctors at Brown.
Then they can likely have it sent to the UK and then they'd have to go there for the injections for now. Once it is approved in the US, they can get the vaccines sent to the US, but not until it is an approved treatment. So they'd need to get a referral from a doctor here to a relevant doctor there, most likely Dr. Ashkan at King's College. They can arrange with their doctor to discuss with NWBO how to prepare their tumor and then get the appropriate leukapheresis, which likely also can be done by their doctor here. But they would likely need to have their doctors coordinate with NWBO and the best likely way to do that is to coordinate with a surgeon / neuro-oncologist who was part of the trial.
Patients in the us can freeze their tumors properly, that is the first suggestion by the doctors at Brown.
Then they can likely have it sent to the UK and then they'd have to go there for the injections for now. Once it is approved in the US, they can get the vaccines sent to the US, but not until it is an approved treatment. So they'd need to get a referral from a doctor here to a relevant doctor there, most likely Dr. Ashkan at King's College. They can arrange with their doctor to discuss with NWBO how to prepare their tumor and then get the appropriate leukapheresis, which likely also can be done by their doctor here. But they would likely need to have their doctors coordinate with NWBO and the best likely way to do that is to coordinate with a surgeon / neuro-oncologist who was part of the trial.
I own NWBO. My posts on iHub are always posted expressly as just my humble opinion (IMHO) and none are advice, just my opinion. I am NOT a financial advisor, and it is assumed that everyone is responsible for their own due diligence.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
